Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Early Stage Candidates
1.2.3 Late Stage Candidates
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Market Perspective (2018-2033)
2.2 Spinal Muscular Atrophy Growth Trends by Region
2.2.1 Global Spinal Muscular Atrophy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Spinal Muscular Atrophy Historic Market Size by Region (2018-2023)
2.2.3 Spinal Muscular Atrophy Forecasted Market Size by Region (2024-2033)
2.3 Spinal Muscular Atrophy Market Dynamics
2.3.1 Spinal Muscular Atrophy Industry Trends
2.3.2 Spinal Muscular Atrophy Market Drivers
2.3.3 Spinal Muscular Atrophy Market Challenges
2.3.4 Spinal Muscular Atrophy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy Players by Revenue (2018-2023)
3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Players (2018-2023)
3.2 Global Spinal Muscular Atrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy Revenue
3.4 Global Spinal Muscular Atrophy Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Revenue in 2022
3.5 Spinal Muscular Atrophy Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy Historic Market Size by Type (2018-2023)
4.2 Global Spinal Muscular Atrophy Forecasted Market Size by Type (2024-2033)
5 Spinal Muscular Atrophy Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy Historic Market Size by Application (2018-2023)
5.2 Global Spinal Muscular Atrophy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Spinal Muscular Atrophy Market Size (2018-2033)
6.2 North America Spinal Muscular Atrophy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Spinal Muscular Atrophy Market Size by Country (2018-2023)
6.4 North America Spinal Muscular Atrophy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy Market Size (2018-2033)
7.2 Europe Spinal Muscular Atrophy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Spinal Muscular Atrophy Market Size by Country (2018-2023)
7.4 Europe Spinal Muscular Atrophy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy Market Size (2018-2033)
8.2 Asia-Pacific Spinal Muscular Atrophy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Spinal Muscular Atrophy Market Size by Region (2018-2023)
8.4 Asia-Pacific Spinal Muscular Atrophy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spinal Muscular Atrophy Market Size (2018-2033)
9.2 Latin America Spinal Muscular Atrophy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Spinal Muscular Atrophy Market Size by Country (2018-2023)
9.4 Latin America Spinal Muscular Atrophy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy Market Size (2018-2033)
10.2 Middle East & Africa Spinal Muscular Atrophy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Spinal Muscular Atrophy Market Size by Country (2018-2023)
10.4 Middle East & Africa Spinal Muscular Atrophy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonis Pharmaceuticals
11.1.1 Lonis Pharmaceuticals Company Detail
11.1.2 Lonis Pharmaceuticals Business Overview
11.1.3 Lonis Pharmaceuticals Spinal Muscular Atrophy Introduction
11.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.1.5 Lonis Pharmaceuticals Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Spinal Muscular Atrophy Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 AveXis
11.3.1 AveXis Company Detail
11.3.2 AveXis Business Overview
11.3.3 AveXis Spinal Muscular Atrophy Introduction
11.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.3.5 AveXis Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Spinal Muscular Atrophy Introduction
11.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Cytokinetics
11.5.1 Cytokinetics Company Detail
11.5.2 Cytokinetics Business Overview
11.5.3 Cytokinetics Spinal Muscular Atrophy Introduction
11.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.5.5 Cytokinetics Recent Development
11.6 Ionis Pharmaceuticals
11.6.1 Ionis Pharmaceuticals Company Detail
11.6.2 Ionis Pharmaceuticals Business Overview
11.6.3 Ionis Pharmaceuticals Spinal Muscular Atrophy Introduction
11.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023)
11.6.5 Ionis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Spinal Muscular Atrophy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Early Stage Candidates
Table 3. Key Players of Late Stage Candidates
Table 4. Global Spinal Muscular Atrophy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Spinal Muscular Atrophy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Spinal Muscular Atrophy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Spinal Muscular Atrophy Market Share by Region (2018-2023)
Table 8. Global Spinal Muscular Atrophy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Spinal Muscular Atrophy Market Share by Region (2024-2033)
Table 10. Spinal Muscular Atrophy Market Trends
Table 11. Spinal Muscular Atrophy Market Drivers
Table 12. Spinal Muscular Atrophy Market Challenges
Table 13. Spinal Muscular Atrophy Market Restraints
Table 14. Global Spinal Muscular Atrophy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Spinal Muscular Atrophy Market Share by Players (2018-2023)
Table 16. Global Top Spinal Muscular Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy as of 2022)
Table 17. Ranking of Global Top Spinal Muscular Atrophy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Spinal Muscular Atrophy Product Solution and Service
Table 21. Date of Enter into Spinal Muscular Atrophy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Spinal Muscular Atrophy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Spinal Muscular Atrophy Revenue Market Share by Type (2018-2023)
Table 25. Global Spinal Muscular Atrophy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Spinal Muscular Atrophy Revenue Market Share by Type (2024-2033)
Table 27. Global Spinal Muscular Atrophy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Spinal Muscular Atrophy Revenue Market Share by Application (2018-2023)
Table 29. Global Spinal Muscular Atrophy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Spinal Muscular Atrophy Revenue Market Share by Application (2024-2033)
Table 31. North America Spinal Muscular Atrophy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Spinal Muscular Atrophy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Spinal Muscular Atrophy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Spinal Muscular Atrophy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Spinal Muscular Atrophy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Spinal Muscular Atrophy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Spinal Muscular Atrophy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Spinal Muscular Atrophy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Spinal Muscular Atrophy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Spinal Muscular Atrophy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Spinal Muscular Atrophy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Spinal Muscular Atrophy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Lonis Pharmaceuticals Company Detail
Table 47. Lonis Pharmaceuticals Business Overview
Table 48. Lonis Pharmaceuticals Spinal Muscular Atrophy Product
Table 49. Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 50. Lonis Pharmaceuticals Recent Development
Table 51. F. Hoffmann-La Roche Company Detail
Table 52. F. Hoffmann-La Roche Business Overview
Table 53. F. Hoffmann-La Roche Spinal Muscular Atrophy Product
Table 54. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 55. F. Hoffmann-La Roche Recent Development
Table 56. AveXis Company Detail
Table 57. AveXis Business Overview
Table 58. AveXis Spinal Muscular Atrophy Product
Table 59. AveXis Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 60. AveXis Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Spinal Muscular Atrophy Product
Table 64. Novartis Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Cytokinetics Company Detail
Table 67. Cytokinetics Business Overview
Table 68. Cytokinetics Spinal Muscular Atrophy Product
Table 69. Cytokinetics Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 70. Cytokinetics Recent Development
Table 71. Ionis Pharmaceuticals Company Detail
Table 72. Ionis Pharmaceuticals Business Overview
Table 73. Ionis Pharmaceuticals Spinal Muscular Atrophy Product
Table 74. Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2018-2023) & (US$ Million)
Table 75. Ionis Pharmaceuticals Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Spinal Muscular Atrophy Market Share by Type: 2022 VS 2033
Figure 3. Early Stage Candidates Features
Figure 4. Late Stage Candidates Features
Figure 5. Global Spinal Muscular Atrophy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Spinal Muscular Atrophy Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Spinal Muscular Atrophy Report Years Considered
Figure 11. Global Spinal Muscular Atrophy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Spinal Muscular Atrophy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Spinal Muscular Atrophy Market Share by Region: 2022 VS 2033
Figure 14. Global Spinal Muscular Atrophy Market Share by Players in 2022
Figure 15. Global Top Spinal Muscular Atrophy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Revenue in 2022
Figure 17. North America Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Spinal Muscular Atrophy Market Share by Country (2018-2033)
Figure 19. United States Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Spinal Muscular Atrophy Market Share by Country (2018-2033)
Figure 23. Germany Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Spinal Muscular Atrophy Market Share by Region (2018-2033)
Figure 31. China Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Spinal Muscular Atrophy Market Share by Country (2018-2033)
Figure 39. Mexico Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Spinal Muscular Atrophy Market Share by Country (2018-2033)
Figure 43. Turkey Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Spinal Muscular Atrophy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Lonis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 47. AveXis Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 49. Cytokinetics Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 50. Ionis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed